help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wellmann, A.
Right arrow Articles by Brinkmann, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wellmann, A.
Right arrow Articles by Brinkmann, U.

American Journal of Pathology, Vol 150, 25-30, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Localization of the cell proliferation and apoptosis-associated CAS protein in lymphoid neoplasms

A Wellmann, L Krenacs, T Fest, U Scherf, I Pastan, M Raffeld and U Brinkmann
Hematopathology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

We have evaluated the expression and distribution of the cellular apoptosis susceptibility (CAS) protein in normal lymphoid tissue and malignant lymphomas. CAS protein, the product of the CAS gene, is associated with microtubules and the mitotic spindle. Immunohistochemistry with an antibody to CAS shows many CAS-positive cells in normal tonsils. The majority of strongly CAS-positive cells were localized to the dark zone of the follicles, whereas the mantle zone and interfollicular areas were essentially negative. Double staining for CAS and Ki-67 revealed co-expression of the two proliferation markers in approximately 85 to 90% of the CAS-positive cells. Different subtypes of lymphomas exhibited varying patterns of CAS expression. Low-grade non-Hodgkin's lymphoma generally revealed weak staining with CAS, with 10 to 60% of all cells being positive. In contrast, highly malignant non-Hodgkin's lymphoma and malignant cells of Hodgkin's disease displayed very strong CAS positivity, with staining of up to 80% of the atypical cells. Overall, the staining pattern of CAS and Ki-67 was superimposable within a particular lymphoma subtype. However, in all lymphomas we observed a significant fraction of CAS-positive normal and malignant lymphocytes that were Ki- 67 negative, probably because they were momentarily noncycling cells. We conclude that a high expression of CAS correlates with proliferation of normal and malignant lymphoid cells. The fact that detection of CAS protein identifies a higher portion of proliferating and malignant cells than Ki-67 warrants further evaluation of CAS protein as a marker with a diagnostic potential.


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
T. K. Bera, J. Bera, U. Brinkmann, L. Tessarollo, and I. Pastan
Cse1l Is Essential for Early Embryonic Growth and Development
Mol. Cell. Biol., October 15, 2001; 21(20): 7020 - 7024.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Rogatsky, A. B. Hittelman, D. Pearce, and M. J. Garabedian
Distinct Glucocorticoid Receptor Transcriptional Regulatory Surfaces Mediate the Cytotoxic and Cytostatic Effects of Glucocorticoids
Mol. Cell. Biol., July 1, 1999; 19(7): 5036 - 5049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.